November
Falling US vaccine rates have hit CSL. They might help it recover, too
The group says its vaccine business will recover in the medium term when falling immunisation rates cause a severe public health crisis and reverse the hesitancy.
September
Sorry, Mr President, but parents should seek a second opinion
Donald Trump ignored facts and instead relied on gut feel, a personal anecdote and a dangerous ability to see wokeness everywhere to sow doubt over vaccinations.
Trust me, I’m a doctor. Paracetamol is safe during pregnancy
From paracetamol to measles vaccination, the failures of US health policy speak to the broader tragedy of its politics: a loss of and centrism.
August
Inside RFK’s dangerous purge of US vaccine experts
The US health secretary’s sacking of the head of the Centres for Disease Control is his latest move to roll back science-based decisions.
Brokers downgrade CSL, question vaccine spinoff plan
Barrenjoey and Bell Potter have downgraded ratings and voiced concerns about plans to spin off Seqirus, but others have doubled down on their bullish call.
Roundtable must reform the super performance test
Funds should be able to invest more in promising local innovations, keeping IP in Australia and boosting productivity while generating returns for members.
February
CSL war games manufacturing network in a world heading for trade war
The ASX-listed giant says it can switch manufacturing sites if Donald Trump imposes tariffs on pharmaceuticals. It expects double-digit earnings growth.
January
Why it’s a bad year for holidaymakers bringing flu home from Europe
Australians holidaying in the northern hemisphere are returning with nasty strains of influenza which experts blame on low immunisation rates since the COVID-19 pandemic.
How Formula 1 engineers turbocharged a $200b public company
Australian CEOs are often shy to talk about how and when they use external consultants. The boss of this big French company, which plays an important role in Australia’s health system, isn’t.
December 2024
Bill Gates believes the world is at a dangerous tipping point
The philanthropist has been fighting global disease for 25 years. He is now wrestling with the optimist’s dilemma.
November 2024
CSL tumbles as investors fear RFK jnr’s vaccine plans
The White House appointment of the anti-vax conspiracy theorist is devastating ASX healthcare and biotech shares as he threatens to turn the FDA ‘on its head’.
October 2024
US-style CDC to co-ordinate response, combat fake news
A new agency will be charged with preparing against infectious disease, after a review found a lack of real-time data reduced trusts in pandemic restrictions.
We should never see such an old-school pandemic response again
At the next pandemic, Australia should focus on key risk groups and be driven by reliable official public data.
September 2024
How Australia crushed the COVID curve and lost the race
This country had one of the best-designed economic responses in the world, and one of the worst vaccine procurement processes.
May 2024
Anti-vax claims flood Senate inquiry. Officials say they’re wrong
The ABS, Health Department and actuaries say there is no evidence to support claims there were more deaths from non-COVID causes due to government vaccine mandates during the pandemic.
February 2024
COVID-19 causes lasting cognitive, memory damage: major study
“Brain fog” was detectable in long and short-term cases, a detailed study suggests.
January 2024
Controlling COVID ‘at all costs’ went too far: ex-deputy health chief
Officials persisted with policies despite the changing nature of the pandemic, while state powers on lockdowns need to be reined in, Dr Nick Coatsworth said.
December 2023
COVID-19 warning ahead of New Year’s Eve parties
Case numbers are soaring across Australia, with experts warning that low testing rates mean infection rates are much higher than official tallies suggest.
October 2023
Crescent Capital claims stake in clinical trials biz Walski
Michael Alscher’s healthcare-focused private equity firm is making another play in its favourite sector.
September 2023
It’s back: UK ramps up COVID jabs amid fears over Pirola variant
The “most concerning variant since omicron” spurs an early start, and more money, for England’s winter vaccination campaign.